InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Szekeres David Leslie, Chief Executive Officer. Officer active across 2 companies, notably Heron Therapeutics, INC.. In total, 12 disclosures have been logged. Activity tracked since 30 April 2021. The latest transaction was filed on 31 October 2022 (J). Regulator: SEC (Form 4). All data is free.
Declarations12 total
1,250 sharesCommon StockSEC:0001209191-23-042480:0
1,250 sharesCommon StockSEC:0001209191-23-024500:0
●
1,654 shares@ US$3.272549.7% of flowCommon StockSEC:0001209191-23-003564:0
1,250 sharesCommon StockSEC:0001209191-22-053836:0
●
1,505 shares@ US$3.84250.3% of flowCommon StockSEC:0001209191-22-042263:0
1,250 sharesCommon StockSEC:0001209191-22-024523:0
1,250 sharesCommon StockSEC:0001209191-22-003364
1,250 sharesCommon StockSEC:0001209191-22-003364:0
1,250 sharesCommon StockSEC:0001209191-21-060553:0
1,250 sharesCommon StockSEC:0001209191-21-060553
1,530 shares@ US$13.897550.0% of flowCommon StockSEC:0001209191-21-046791
1,530 shares@ US$13.89750.0072% mcap50.0% of flowCommon StockSEC:0001209191-21-046791:0
12 of 12 declarations
About Szekeres David Leslie
David Leslie Szekeres is the Chief Operating Officer at HERON THERAPEUTICS, INC. He oversees the company's operations and implements strategies to enhance efficiency. His expertise in the pharmaceutical sector is essential for the company's growth.
